Makers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Key Takeaways Semaglutide is associated with a slightly increased risk of a potentially blinding eye conditionPeople taking ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...